CHDNEUTRAL

P/E Ratio

31.9x

Updated 368h ago

Sector Performance

67th percentile

CHD

31.9x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current P/E ratio of 31.9x means that investors are paying $31.90 for every $1.00 of the company’s trailing earnings—a valuation measure often used to gauge whether a stock is expensive or cheap relative to its profits.

Compared to sector peers, CHD trades above the sector median of 23.8x and sits at the 69th percentile, indicating it is more expensive than roughly two-thirds of similar companies. The year-over-year change is not available, but the quarter-over-quarter change shows a +1.5% increase from the prior quarter’s 31.4x. Together, the above-median P/E combined with a slight upward trend suggests a premium that may carry added risk if earnings growth fails to justify the multiple, yet it does not point to an extreme overvaluation. This metric supports the overall NEUTRAL verdict because while CHD is priced above its sector norm, the moderate increase and lack of dramatic deviation leave room for either upside or downside.

Frequently Asked Questions

What does the P/E Ratio tell investors about CHD?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are CHD's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master CHD's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CHD research report

Free account — no credit card

CHD

31.9x

Sector Median

24.7x

Sector Avg

36.0x

How CHD's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.